Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
ACTIVE_NOT_RECRUITING
Status
Conditions
- Hypoplastic Left Heart Syndrome
Interventions
- BIOLOGICAL: Lomecel-B medicinal signaling cells
Sponsor
Longeveron Inc.
Collaborators
- [object Object]
- [object Object]
- [object Object]